SciELO - Scientific Electronic Library Online

 
vol.4 número4Community pharmacy-based intervention to improve self-monitoring of blood glucose in type 2 diabetic patien índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Pharmacy Practice (Granada)

versión On-line ISSN 1885-642X

Pharmacy Pract (Granada) vol.4 no.4  oct./dic. 2006

 

Original Research

Assessment of the decreased productivity of patients with diabetes type 2 in the Clinical Endocrynological Center Sofia, Bulgaria

Ognian PLAVEEV, Zlatka DIMITROVA., Nedialka OVCHAROVA, Valentina PETKOVA, Mona STEFANOVA, Stela IVANOVA.

ABSTRACT

This study aims to assess the influence of type 2 diabetes on the patients’ productivity and quality of life.
The WHO’s methodology – HLQ (Health and Labor Questionnaire) is applied. Subjects were 38 patients with type 2 diabetes, diagnosed and treated at the Clinical center on endocrinology at the MU-Specialized hospital center for active treatment-Sofia. Control consisted of 100 patients without diabetes.
The results from the study proofs the fact that the patients with type 2 diabetes manage with their day-to-day activities like their colleagues and even better, but they absent from work because of: their illness, experiencing fatigue and insomnia, pain in hands, legs, joints and muscles. They receive hospital treatment because of the insufficient control on their treatment and the advanced diabetes complications. The application of the Osterhaus method establishes that type 2 diabetes is connected with the excess illness-related work loss and with more often “medically related absences”. These do not lead to significant indirect productivity costs because these patients are with lower income. The cumulative costs from the sporadic work loss during their whole life are even greater, because of the increased spread of the disease, suboptimum treatment, and many complications and prolonged life duration thanks to the contemporary medicine.

Key words: Diabetes Mellitus, Type 2. Quality of Life. Sick Leave. Efficiency. Bulgaria.

RESUMEN

Este estudio intenta evaluar la influencia de la diabetes tipo 2 sobre la productividad y la calidad de vida de los pacientes.
Se aplicó la metodología de la OMS – Cuestionario Salud y Trabajo). Los sujetos fueron 38 pacientes con diabetes tipo 2, diagnosticados y tratados en el servicio médico de endocrinología del Hospital Especializado MU para tratamientos activos de Sofía (Bulgaria). El control consistió en 100 pacientes son diabetes.
Los resultaos prueban que el hecho de que los pacientes con diabetes tipo 2 realizan sus actividades diarias como sus colegas e incluso mejor, pero se ausentan del trabajo a causa de: su enfermedad; experimentar fatiga e insomnio; dolor de manos, piernas articulaciones y músculos. Reciben tratamiento hospitalario a causa de control insatisfactorio de su tratamiento; y avance de las complicaciones de la diabetes. La aplicación del método Osterhaus establece que la diabetes tipo 2 esta asociada con excesiva perdida de trabajo relacionada con la enfermedad y con “ausencias relacionadas con médicos” más frecuentes. Esto no lleva a significativos costes de productividad indirectos porque estos pacientes son los de más bajos ingresos. Los costes acumulativos de las pérdidas esporádicas de trabajo durante toda su vida son mayores, por la mayor extensión de la enfermedad, tratamiento no idóneo, y muchas complicaciones y aumento de duración de la vida debido a la medicina moderna.

Palabras clave: Diabetes mellitus tipo 2. Calidad de vida. Baja laboral. Eficiencia. Bulgaria.


Ognian PLAVEEV. PhD student. Department of Social Pharmacy, Pharmaceutical faculty, Medical University-Sofia (Bulgaria).
Zlatka DIMITROVA. DSc. Professor. Department of Social Pharmacy, Pharmaceutical faculty, Medical University-Sofia (Bulgaria).
Nedialka OVCHAROVA. MD, DSc. Professor. Medical University, Sofia (Bulgaria).
Valentina PETKOVA. PhD. Assistant Professor. Department of Social Pharmacy, Pharmaceutical faculty, Medical University-Sofia (Bulgaria).
Mona STEFANOVA. PhD. Assistant Professor. Department of Social Pharmacy, Pharmaceutical faculty, Medical University-Sofia (Bulgaria).
Stela IVANOVA. Department of Social Pharmacy, Pharmaceutical faculty, Medical University-Sofia (Bulgaria).

 

INTRODUCTION

Diabetes mellitus is a chronic disease that requires long-term medical care, both to limit the development of its devastating complications and to manage them when they occur. It is a disproportionately expensive disease; patients with diabetes accounted for 170 million people world wide according to World Health Organization (WHO) and it predicts that their number may double to 300 million by 2025 because of the rising incidence of obesity in an ageing population.1

The number of the Bulgarian diabetic patients is about 400,000. Approximately 90% of the diagnosed patients have type 2 diabetes mellitus. The diabetic patients live significantly shorter than non-diabetics (average 5 to 10 years). Diabetes is associated with many chronic vascular complications such as retinopathy, nephropathy, and neuropathy.2,3

Type 2 diabetes causes also fatigue, frequent urination and lack of concentration during work.4

The objective of this study was to investigate the influence of the type 2 diabetes on patients’ work productivity.

 

METHODS

The study population was drawn out with specialists’ recommendation from the Clinical center on endocrinology at the MU-Specialized hospital center for active treatment-Sofia, focussing only on patients with type 2 diabetes. From all the 75 patients with type 2 diabetes only 38 agreed to participate in the study and filled in the WHO’s Health and Labour Questionnaire (HLQ). The excluding criteria were patients with type 1 diabetes, unemployed or having one or more additional diseases.

The control group is a stratified sample randomly chosen. After the study of the voluntaries there were 161 people without diabetes, that were chosen and that filled in the same questionnaire.

The HLQ, aims to measure time costs due to the disease by:
- asking individuals, on a daily basis, whether they have been engaged in paid work, or been unable to do so due to illness or other reasons;
- measuring productivity losses due to illness without being absent from employment through asking individuals how many additional hours they would have to work to compensate for loss of work time;
- measuring loss of time in unpaid employment, in particular, shopping, caring for children and household work; and
- investigating aspects of illness that impair affected persons from engaging in paid work.1,5

The Osterhaus method aims to measure time lost as a result of the efficiency loss when ill individuals continue to go to work. The time lost is measured by the following formula:

RP = HWs x DMO x (100% - PWsx) x EH

where: RP = reduced productivity; HWs = work off hours (per day) with symptoms; DMO = work off days (per month), feeling bad; %PWsx = productivity in per cent when feeling bad; EH = individual hour stake.6

The individual income per hour is calculated by the personal annual income, stated by every participant.

In order to compute the work-loss days, the total productivity loss and the cost of this time, we used a Tobit regression technique, because many participants announced value zero for their loss of productivity. We used chi square – the Pearson correlation criterion and the criterion of Likelihood Ratio to evaluate the statistical significance of correlation between the answers and the corresponding factor. It is accepted that such a correlation exists if the p-value is lower than 0.05. This correlation is strongly expressed if p< 0.001.

 

RESULTS

The characteristics of the 38 patients who participated in the study are shown on Table 1.

It can be seen that there is a prevalence of the female – 78.9%, although the analysis of the data for a 3-years period of time shows that both sexes suffer from type 2 diabetes with a little prevail of women. The average age of the patients is 53.97 years (minimum 23 years, maximum 80 years), and the disease duration since diagnosis is 15.6 years (SD=8.06) and varies from 10 to 37 years. Near half of the patients (42%) are retired, but small part of them continues to work. About half of the patients (54.0%) present basic and secondary education and only 18.4% have a high education and even have masters degree. 55% of the patients have 120 BGN (61 euros) average monthly income or lower. Only 16% are with income above 250 BGN (128 euros), and 29% are with monthly income between 120 and 250 BGN (128 euros). 3% have not communicated their monthly income. According to the collected data, the most often comorbidities are arterial hypertension (60%), high level of cholesterol (37%), hearth diseases (48%) and myocardial infarction (29%). The most frequent symptoms, experienced during the last month, were sleep disturbances, fatigue, pain in hands, feet, joints, muscle pain and headache. They are presented in three degrees - severe, significant and insignificant, according to the subjective patients’ assessment (Table 2).
The table 3 shows the results from the answers, connected with the patients’ concentration at work during their illness.

The analysis shows that there is a statistically significant correlation between the questions “How do you assess your current health status” and “How do you assess your current psychical health” and the following factors: gross monthly income; availability of frequent and heavy headache; and heart attack.

55.0% of the patients are with minimum income (up to 120 BGN about 61 euros) and they assess their health condition as satisfactory or bad (36.8% and 31.6% respectively). Only 16.0% are with income between 250-500 BGN (128-256 euros). and they assess in equal parts (30.3%) their health condition as excellent, very good and satisfactory.

During the second statistical proceeding of the questionnaires the answers for one and the same question, given from the representatives of the main (38 diabetic patients) and of the control (100 healthy patients) groups are compared. The aim is to be determined if there is any statistically significant correlation between the answer and the affiliation of the participant to one of the above mentioned groups. The Likelihood Ratio is applied and the p-values are calculated as indexes of such correlation.

 

DISCUSSION

The results from this study show the influence of the disease on the patients’ productivity. It is observed a significant positive correlation (p<0.001) between the affiliation of the participants to the two different groups and the answers to the questions “How do you assess your health in the moment” and “How do you assess your psychical health in the moment”. 28.9% from the diabetic patients assess their current health condition as satisfactory and 31.6% - as bad while only 18.1% state satisfactory and 5% bad in the control group. Near 78% (above 2/3) from the control group assess their health status as excellent, very good and good or the disease diabetes has a negative influence on the self-perception of their health status. The correlation between the answers and the patient’s affiliation to one of the groups is statistically significant for the question “Do you suffer from one of the following diseases – frequent and heavy headache; availability of chronic pain; high blood pressure; stroke; chronic lung disease; high cholesterol in the blood; obesity” (p<0.05). This correlation is high when there is diabetes, chronic fatigue and skin cancer (p<0.001).

About half (45%) of the diabetic patients are obese while only 24.5% of the control group are obese. The correlation between the answers and the patient’s affiliation to one of the groups is statistically significant for the question “During the last four weeks how often did you feel one of the following symptoms – fatigue, sleep disturbances, pain in the hands, legs, joints, muscle pains” (p<0.05). A strongly expressed statistical correlation between the answers and the patient’s affiliation to one of the groups is observed for the question “During the last four weeks how often did you feel yourself sad, desperate, everything was a burden for me” (p<0.001). The correlation between the answers and the patient’s affiliation to one of the groups is statistically significant for the question “How many times during the last 12 months you have visited a specialist – dentist, ophthalmologist, psychiatrist” (p<0.05).

This correlation is highly expressed (p<0.001) after the visit of first aid, and ophthalmologist for a plan’s operation.

A significant positive correlation is found between the answers and the patient’s affiliation to one of the groups for the question “How many twenty-four hours you have spent in a hospital during the last 12 months” (p<0.001). There is no statistically significant correlation for the following conditions: nervous, anxious, and useless. The diabetic patients do not have the feeling that they are useless, but they have some troubles and they have to have “medically related absences” from work because of their disease. There is no statistically significant correlation between the answer of the question “How many working days you have lost because of a working accident” and the affiliation of the patients to one of the groups.

According to the HLQ there were 11 patients from the diabetes group (29%) and 24 patients from the control group (14.3%) that have productivity losses. Although the patients with diabetes have twice more work loss, more disability claims and longer duration of disability, the indirect costs calculated by the Osterhaus formula are 238.88 BGN (about 122.50 €) for the patients with diabetes and 1158 BGN ( about 593.84€) for the control group. Thus diabetes can be connected with a lower socio-economical status. On the other hand the lower remunerations can be due to individual and working interrelations.4,7

 

CONCLUSIONS

We can conclude that type 2 diabetes affects patients from the both sexes (with slight female predominance) and as the age increases the relative rate of complications is increasing. There is inadequate control of patients suffering from type 2 diabetes and the complications lead to increase of the symptoms and to increase of the treatment costs. The diabetes patients manage with their working routine like their other colleagues and even better, but they have work losses because of their disease and they also feel difficulties and fatigue because of their disease. Diabetes is associated with a profound negative impact on patients’ productivity. Its prevention, the better control, and the delay of diabetes complications will decrease the costs.

 

ACKNOWLEDGEMENTS

This project was financed by a grant from the Council of Medical Science, Medical University - Sofia. We are grateful to all the participants who graciously gave of their time to participate in the study. Associate Professor Ovcharova gave us possibility to select the participants among her patients.

 

References

1. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001; 24(3):561-87.        [ Links ]

2. Panja S, Starr B, Colleran KM. Patient knowledge improves glycemic control: is it time to go back to the classroom? J Investig Med 2005; 53(5):264-6.        [ Links ]

3. Hauner H. [Evicende based therapy of obesity]. Internist 2006; 47(2):159-70.        [ Links ]

4. Keers JC, Bouma J, Links TP et al. One-year follow-up effects of diabetes rehabilitation for patients with prolonged self-management difficulties. Patient Educ Couns 2006; 60(1):16-23.        [ Links ]

5. Schiel R, Voigt U, Ross IS, Braun A, Rillig A, Hunger-Dathe W, Stein G, Muller WA. Structured diabetes therapy and education improves the outcome of patients with insulin treated diabetes mellitus. The 10 year follow-up of a prospective, population-based survey on the quality of diabetes care (the JEVIN Trial). Exp Clin Endocrinol Diabetes 2006; 114(1):18-27.        [ Links ]

6. Sonksen PH, Judd SL, Lowy C. Home monitoring of blood-glucose. Method for improving diabetic control. Lancet 1978; 1(8067):729-32.        [ Links ]

7. Walford S, Gale EA, Allison SP, Tattersall RB. Self-monitoring of blood-glucose. Improvement of diabetic control. Lancet 1978; 1(8067):732-5.        [ Links ]

8. Karter AJ, Ackerson LM, Darbinian JA, D’Agostino RB Jr, Ferrara A, Liu J, Selby JV. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111(1):1-9.        [ Links ]

9. Schiel R, Muller UA, Rauchfub J, Sprott H, Muller R. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group. Diabetes Metab 1999; 25(4):334-40.        [ Links ]

10. Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002; 25(11):1928-32.        [ Links ]

11. Dreyer M, Kiess W, Lüdecke H, Redaélli M, Schatz H, Waldhäusl W. Therapie des Diabetes mellitus Typ 1. Evidenzbasierte Diabetes-Leitlinie DDG. Scherbaum WA, Landgraf R (eds.). Diabetes und Stoffwechsel 2003; 12 (Suppl. 2).        [ Links ]

12. Häring H, Joost H, Laube H, Matthaei S, Meissner HP, Panten U, Schernthaner G. Antihyperglykämische Therapie des Diabetes mellitus Typ 2. Evidenzbasierte Diabetes-Leitlinie DDG. Scherbaum WA, Landgraf R (eds.). Diabetes und Stoffwechsel 2003; 12 (Suppl. 2):13-31.        [ Links ]

13. Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects. A criteria-based literature review. Diabetes Care 1997; 20(9):1482-6.        [ Links ]

14. Fontbonne A, Billault B, Acosta M, Percheron C, Varene P, Besse A, Eschwege E, Monnier L, Slama G, Passa P. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete Metab 1989; 15(5):255-60.        [ Links ]

15. Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B, Greenfield S, Kaplan SH, Sacco M, Tognoni G, Valentini M, Nicolucci A, QuED Study Group. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001; 24(11):1870-7.        [ Links ]

16. Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care 2001; 24(6):979-82.        [ Links ]

17. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994; 31(4):215-9.        [ Links ]

18. Rindone JP, Austin M, Luchesi J. Effect of home blood glucose monitoring on the management of patients with non-insulin dependent diabetes mellitus in the primary care setting. Am J Manag Care 1997; 3(9):1335-8.        [ Links ]

19. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49(2):271-8.        [ Links ]

20. Bundesärztekammer. Richtlinie der Bundesärztekammer (BÄK) zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen. Dtsch Ärztebl 2001; 98:A 2747-59.        [ Links ]

21. Thomas A, Hasche H. Anforderungen an die Blutzuckermessgeräte. In: Selbstkontrolle bei Diabetes. Mainz: Kirchheim-Verlag; 2003: 39-42.        [ Links ]

22. Alto WA, Meyer D, Schneid J, Bryson P, Kindig J. Assuring the accuracy of home glucose monitoring. J Am Board Fam Pract 2002; 15(1):1-6.        [ Links ]

23. Delamater AM, Davis SG, Bubb J, Santiago JV, Smith JA, White NH. Self-monitoring of blood glucose by adolescents with diabetes: technical skills and utilization of data. Diabetes Educ 1989; 15(1):56-61.        [ Links ]

24. Kabadi UM, O'Connell KM, Johnson J, Kabadi M. The effect of recurrent practice at home on the acceptability of capillary blood glucose readings. Accuracy of self blood glucose testing. Diabetes Care 1994; 17(10):1110-23.        [ Links ]

25. Kristensen GB, Nerhus K, Thue G, Sandberg S. Standardized evaluation of instruments for self-monitoring of blood glucose by patients and a technologist. Clin Chem 2004; 50(6):1068-71.        [ Links ]

26. Kristensen GB, Nerhus K, Thue G, Sandberg S. Results and feasibility of an external quality assessment scheme for self-monitoring of blood glucose. Clin Chem 2006; 52(7):1311-7.        [ Links ]

27. Schrot RJ, Foulis PR, Morrison AD, Farese RV. A computerized model for home glucose monitoring proficiency testing: efficacy of an innovative testing program. Diabetes Educ 1999; 25(1):48-55.        [ Links ]

28. Skeie S, Thue G, Nerhus K, Sandberg S. Instruments for self-monitoring of blood glucose: comparisons of testing quality achieved by patients and a technician. Clin Chem 2002; 48(7):994-1003.        [ Links ]

29. Ward WK, Haas LB, Beard JC. A randomized, controlled comparison of instruction by a diabetes educator versus self-instruction in self-monitoring of blood glucose. Diabetes Care 1985; 8(3):284-6.        [ Links ]

30. Bergenstal R, Pearson J, Cembrowski GS, Bina D, Davidson J, List S. Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy. Diabetes Educ 2000; 26(6):981-9.        [ Links ]

31. Dorchy H, Van Vlaenderen C, Roggemans MP. [Sources of errors in blood glucose self-monitoring in 100 young diabetics]. Rev Med Brux 2003; 24(2):77-81.        [ Links ]

32. Perwien AR, Johnson SB, Dymtrow D, Silverstein J. Blood glucose monitoring skills in children with Type I diabetes. Clin Pediatr 2000; 39(6):351-7.        [ Links ]

33. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care 1990; 13(Supplement 1):S62-6.        [ Links ]

34. American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 2004; 27 [Supplement]:S91-3.        [ Links ]

35. Eickhoff C, Schulz M. Einbindung der Apotheker in die Diabetikerversorgung. Pharm Ztg 2000; 145(7):512-4.        [ Links ]

36. Krüger M. MessTest-Aktion.Personal communication, 2002.        [ Links ]

37. Mangiapane S; Schulz M; Muhlig S; Ihle P; Schubert I; Waldmann H C. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother 2005; 39(12):1817-22.        [ Links ]

38. Meadows S. Improving blood glucose monitoring for diabetes. FDA Consum 1990; May.        [ Links ]

39. Steel LG. Identifying technique errors. Self-monitoring of blood glucose in the home setting. J Gerontol Nurs 1994; 20(2):9-12.        [ Links ]

40. Gerdemann A, Müller U, Schulz M. Akzeptanz und Evaluation der zertifizierten Diabetes-Fortbildung. Pharm Ztg 2004; 149(46):4052-4.        [ Links ]

41. Krüger M. Stufenkonzept: Diabetische Patienten qualifizierter betreuen. Pharm Ztg 2000; 145(45):3812-4.        [ Links ]

42. Müller U, Hämmerlein A, Schulz M. Blutzucker fehlerfrei selbst bestimmen. Pharm Ztg 2005; 150(38):3396-7.        [ Links ]

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons